Direct and indirect effects of synthetic dual TLR-2 and TLR-7 agonists (Dual TLR-2/7) on latent HIV
Saved in:
Main Authors: | A.B. Macedo (Author), C.L. Novis (Author), A.M. Spivak (Author), V. Planelles (Author), J. Szu-han Huang (Author), Y. Ren (Author), R. Brad Jones (Author), A. Bosque (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CL572, a potent agonist of Toll-like receptor 2/7, as a novel latency-reversing agent
by: A. Macedo, et al.
Published: (2015) -
The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
by: Mohsin H. K. Roshan, et al.
Published: (2016) -
TLR2 and TLR4 in Ischemia Reperfusion Injury
by: F. Arslan, et al.
Published: (2010) -
BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
by: Deepender Kaushik, et al.
Published: (2020) -
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
by: Aashna Jassal, et al.
Published: (2024)